Evidence map›Paper›PMID 27419074›Full record

ArticleIDCases2016

Chryseobacterium gleum pneumonia in an infant with nephrotic syndrome.

Baha Abdalhamid, Nasreldin Elhadi, Khaldoon Alsamman, Reem Aljindan

Open access · goldAbstract readCase Reports
In one paragraph

Article in IDCases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 34 citations in OpenAlex.

  1. Meningitis due to pandrug resistant Chryseobacterium gleum: microbiological cure and clinical response with linezolid-based combination therapy.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  2. First Case ofReports (MDPI) · 2024
    Article
  3. Microorganisms · 2023
    Article
  4. Emerging Bacterial Pathogens in the COVID-19 Era:Journal of laboratory physicians · 2023
    Article
  5. Review
  6. Article
  7. New microbes and new infections · 2021
    Article
  8. Article
  9. Article
  10. Simultaneous isolation ofJMM case reports · 2017
    Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Baha AbdalhamidDepartment of Pathology and Laboratory Medicine, King Fahad Specialist Hospital, P.O. Box 15215, Dammam, Saudi Arabia.
Nasreldin ElhadiDepartment of Clinical Laboratory Science, College of Applied Medical Science, University of Dammam, P.O. Box 2208, AlKhobar, Saudi Arabia.
Khaldoon AlsammanDepartment of Clinical Laboratory Science, College of Applied Medical Science, University of Dammam, P.O. Box 2208, AlKhobar, Saudi Arabia.
Reem AljindanDepartment of Microbiology, College of Medicine, University of Dammam, P.O. Box 2208, AlKhobar, Saudi Arabia.
Imam Abdulrahman Bin Faisal University · SAKing Fahad Specialist Hospital · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionChryseobacterium gleum is commonly distributed in the environment. It can cause a wide variety of infections in immunocompromised patients in hospital setting. CASE PRESENTATION: A 6 month old infant with nephrotic syndrome was admitted to the emergency room for an acute onset of fever, difficulty breathing, cyanosis, and low oral intake. Cultures of endotracheal tube specimens were positive for Chryseobacterium gleum which was confirmed by ribosomal sequencing. The organism was susceptible to trimethoprim-sulfamethoxazole, minocycline, and levofloxacin. The patient clinically improved on levofloxacin treatment.

conclusionTo the best of our knowledge, this is the first case of pneumonia caused by Chryseobacterium gleum in an infant with nephrotic syndrome. It is also the first report of C. gleum causing respiratory tract infection in Saudi Arabia.

Indexed as

Chryseobacterium gleumLevofloxacinMultiple drug resistanceNephrotic syndrome

Identifiers

PMID27419074
PMCPMC4941117
OpenAlexW2463810463

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.